Triglyceride uptake and lipoprotein lipase-generated fatty acid spillover in the splanchnic bed of dogs

Diabetes

Volumn 56, Issue 7, 2007, Pages 1850-1855

  Nelson, Robert H ^a   Edgerton, Dale S ^b   Basu, Rita ^a   Roesner, Justin C ^a   Cherrington, Alan D ^b   Miles, John M ^a  

^a MAYO CLINIC   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; LIPID EMULSION; LIPOPROTEIN LIPASE; OLEIC ACID; TRIACYLGLYCEROL; TRIOLEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; FATTY ACID TRANSPORT; HEPATIC VEIN; INTRAABDOMINAL FAT; LIPID STORAGE; LIPOLYSIS; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ANIMALS; DOGS; FATTY ACIDS, NONESTERIFIED; LIPOPROTEIN LIPASE; LIVER; SPLANCHNIC CIRCULATION; TRIGLYCERIDES;

EID: 34347396737     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-1657     Document Type: Article

References (30)

1. Farrell JJ: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th ed. Feldman MD, Ed. Philadelphia, Saunders, 2002
2. Miles J, Park Y, Walewicz D, Russell-Lopez C, Windsor S, Isley W, Coppack S, Harris W: Systemic and forearm triglyceride metabolism: fate of lipoprotein lipase-generated glycerol and free fatty acids. Diabetes 53:521-527, 2004
3. Tan GD, Fielding BA, Currie JM, Humphreys SM, Desage M, Frayn KN, Laville M, Vidal H, Karpe F: The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia 48:83-95, 2005
4. Barrows BR, Timlin MT, Parks EJ: Spillover of dietary fatty acids and use of serum nonesterified fatty acids for the synthesis of VLDL-triacylglycerol under two different feeding regimens. Diabetes 54:2668-2673, 2005
5. Evans K, Burdge GC, Wootton SA, Clark ML, Frayn KN: Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle. Diabetes 51:2684-2690, 2002
6. Jensen MD, Sarr MG, Dumesic DA, Southorn PA, Levine JA: Regional uptake of meal fatty acids in humans. Am J Physiol Endocrinol Metab 285:E1282-E1288, 2003
7. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD: Splanchnic lipolysis in human obesity. J Clin Invest 113:1582-1588, 2004
8. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
9. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G: Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95:158-166, 1995
10. Stevenson RW, Steiner KE, Connolly CC, Fuchs H, Alberti KG, Williams PE, Cherrington AD: Dose-related effects of epinephrine on glucose production in conscious dogs. Am J Physiol 260:E363-E370, 1991
11. Miles JM, Ellman MG, McClean KL, Jensen MD: Validation of a new method for determination of free fatty acid turnover. Am J Physiol 252:E431-E438, 1987
12. Park Y, Grellner WJ, Harris WS, Miles JM: A new method for the study of chylomicron kinetics in vivo. Am J Physiol 279:E1258-E1263, 2000
13. Miles JM, Glasscock R, Aikens J, Gerich JE, Haymond MW: A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 24:96-99, 1983
14. Jensen MD, Rogers PJ, Ellman MG, Miles JM: Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism. Am J Physiol 254:E562-E565, 1988
15. Dole VP, Meinertz H: Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem 235:2595-2599, 1960
16. Mittendorfer B, Liem O, Patterson BW, Miles JM, Klein S: What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes 52:1641-1648, 2003
17. Jensen MD, Cardin S, Edgerton D, Cherrington A: Splanchnic free fatty acid kinetics. Am J Physiol 284:E1140-E1148, 2003
18. Borensztajn J: Lipoprotein Lipase. Chicago, Evener, 1987
19. Quarfordt SH, Hanks J, Shelburne F, Schirmer B: Differing uptake of emulsion triglyceride by the fed and fasted rat liver. J Clin Invest 69:1092-1098, 1982
20. Bergman EN, Havel RJ, Wolfe BM, Bohmer T: Quantitative studies of the metabolism of chylomicron triglycerides and cholesterol by liver and extrahepatic tissues of sheep and dogs. J Clin Invest 50:1831-1831, 1971
21. Kortz WJ, Schirmer BD, Mansbach CM II, Shelburne F, Toglia MR, Quarfordt SH: Hepatic uptake of chylomicrons and triglyceride emulsions in rats fed diets of differing fat content. J Lipid Res 25:799-804, 1984
22. Fraser R, Dobbs BR, Rogers GW: Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 21:863-874, 1995
23. Cooper AD: Hepatic uptake of chylomicron remnants. J Lipid Res 38:2173-2192, 1997
24. Redgrave TG, Maranhao RC: Metabolism of protein-free lipid emulsion models of chylomicrons in rats. Biochim Biophys Acta 835:104-112, 1985
25. Wolfe RR, Shaw JHF, Durkot MJ: Effects of sepsis on VLDL kinetics: responses in basal state and during glucose infusion. Am J Physiol 248:E732-E740, 1985
26. Gormsen LC, Jensen MD, Nielsen S: Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer. J Lipid Res 47:99-106, 2006
27. Coppack SW, Fisher RM, Gibbons GF, Humphreys SM, McDonough MJ, Potts JL, Frayn KN: Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clin Sci 79:339-348, 1990
28. Nelson RH, Prasad A, Lerman A, Miles JM: Myocardial uptake of circulating triglycerides in nondiabetic patients with heart disease. Diabetes 56:527-530, 2007
29. Bickerton AS, Roberts R, Fielding BA, Hodson L, Blaak EE, Wagenmakers AJ, Gilbert M, Karpe F, Frayn KN: Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period. Diabetes 56:168-176, 2007
30. Miles JM, Jensen MD: Counterpoint: visceral adiposity is not causally related to insulin resistance. Diabetes Care 28:2326-2328, 2005